Sources | Names Used |
---|---|
GDSC1000 | KIN001-260 |
PharmacoGx | KIN001-260 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ENY2 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.05 |
mRNA | TRPV5 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.05 |
mRNA | CACNA1E | GDSC1000 | pan-cancer | AAC | 0.059 | 0.05 |
mRNA | KRI1 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
mRNA | OSBPL3 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
mRNA | SPRY2 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
mRNA | RFC5 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.06 |
mRNA | PDE3B | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
mRNA | LRRC20 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
mRNA | GDF6 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.06 |